1 Log-linear regressions
were adjusted for a priori selected covariates to determine d
2 ducation, and insurance status were assessed in models that
were adjusted for age and each of the other factors.
3 Comparisons between treated and untreated eyes
were adjusted for age and other confounding variables.
4 dimensional statistical analyses were performed, all models
were adjusted for age and smoking, and p-values were adjusted
5 All results
were adjusted for age, body mass index, and mean arterial pre
6 Measures of association
were adjusted for age, diabetes, smoking, American Society of
7 Models
were adjusted for age, race or ethnicity, smoking, hepatitis
8 Survival models
were adjusted for age, sex, alcohol intake, smoking history,
9 ific survival (MSS) estimates up to 5 years after diagnosis
were adjusted for age, sex, and 8th edition American Joint Co
10 Models
were adjusted for age, sex, and BMO area.
11 Analyses accounted for the complex sampling design and
were adjusted for age, sex, and race.
12 tested with the use of Cox proportional hazards models that
were adjusted for age, sex, body mass index, smoking status,
13 P values
were adjusted for age, sex, carotid artery site, and family r
14 Models
were adjusted for age, sex, race/ethnicity, education, employ
15 Models accounted for familial relatedness and
were adjusted for age, sex, total arsenic levels, and populat
16 In multivariable models that
were adjusted for age, sex, urban or rural residence, and soc
17 HRs
were adjusted for age, smoking status, and education level, a
18 Analyses
were adjusted for age, Tyrer-Cuzick risk, smoking, use of hor
19 ut not on laminar depth, changes in neuroretinal parameters
were adjusted for age-related reduction.
20 Final multivariate models
were adjusted for age.
21 These data
were adjusted for all-cause mortality with data from the Offi
22 Models
were adjusted for calendar time and other potential confoundi
23 Cox proportional hazards regression models
were adjusted for cardiovascular disease risk factors.
24 ression models were used to estimate odds ratios (ORs) that
were adjusted for comorbidity, education level, and income le
25 Rate ratios
were adjusted for covariates (diabetes mellitus, myocardial i
26 Estimates
were adjusted for delay in diagnosis and reporting by weighti
27 all models were adjusted for age and smoking, and p-values
were adjusted for false discovery.
28 Costs
were adjusted for inflation and reported in 2015 dollars.
29 Costs
were adjusted for inflation to 2014 US dollars.
30 Prices
were adjusted for inflation.
31 Estimates
were adjusted for maternal and pregnancy characteristics, soc
32 difference observed in subgroup analyses (n = 27,395) that
were adjusted for maternal stature (P < 0.001).
33 P-values
were adjusted for multiple comparisons, and permutation testi
34 Analysis was performed using Phyloseq and DESeq2; P-values
were adjusted for multiple comparisons.
35 All models
were adjusted for patient and hospital characteristics to acc
36 Odds ratios (ORs) and 95% CIs
were adjusted for patient demographics and baseline risk fact
37 All models
were adjusted for patient demographics, comorbidities, severi
38 Models
were adjusted for potential confounders and energy misreporti
39 plications, and a range of other known ADPKD manifestations
were adjusted for potential confounders.
40 Analyses
were adjusted for potential confounders.
41 Analyses
were adjusted for potential confounding due to age, sex, smok
42 Outcomes
were adjusted for potential sociodemographic, maternity, and
43 When the FCAT test scores
were adjusted for potentially confounding maternal and infant
44 min intravenous infusion every 8 h) for 7-14 days; regimens
were adjusted for renal function.
45 Analyses
were adjusted for sex, study center, and educational level, a
46 , carotenoid values were inverse normalized, and all traits
were adjusted for significant covariate effects of age and se
47 Models
were adjusted for socio-economic development and wider health
48 The effects of physical activity on mortality and CVD
were adjusted for sociodemographic factors and other risk fac
49 Estimates
were adjusted for the presence of comorbidities and are repor
50 Analyses
were adjusted for the prognostic stage, size, grade, and necr